CHARLOTTE, N.C. (QUEEN CITY NEWS) — As the popularity of GLP-1 medications for weight loss continues to soar, experts in ...

Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Drugs such as Ozempic, Wegovy, and Zepbound have become increasingly common, with studies estimating that roughly 12% of U.S. adults have used a GLP-1 medication.

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, , MD, an endocrinologist and assistant ...